Coronavirus update: The study published in the journal Science Immunology says that specific cells in the immune system called memory B cells 'remember' the infection

Dr Panda struck a cautious tone and said, 'We need to keep a track of humans infected...If all the clinical indications like the severity of the disease, fatality rate are remaining low, we don't need to panic at all but we need to be watchful'

The Lancet report claimed that the indoor or household air pollution led to 64% fewer deaths in the last two decades (1990-2019) in the country, but outdoor or ambient air pollution, is not only increasing but also killing more people

The Phase 3 clinical trials of Covaxin began in mid-November with a target of 26,000 volunteers. Bharat Biotech's is the first and only Phase 3 efficacy study for a vaccine developed in the country

As many as 341 new fatalities were reported in the past 24 hours, pushing the overall death toll to 1,45,477.  India's COVID-19 case fatality rate is 1.45 per cent, which is one of the lowest in the world

The COVID-19 vaccine in India will be first offered to healthcare workers, frontline workers and persons above 50 years of age. Depending on the disease epidemiology and vaccine's availability, the remaining population will be vaccinated later on

Despite the rise in cases, India's Covid-19 recoveries have witnessed a steep exponential rise -- from 50,000 in May to over 95 lakh in December. Recoveries are more than 30 times active cases, says  HealthMin

The All India Institute of Medical Sciences (AIIMS) in the national capital is one of the sites conducting the final phase of the trial of the vaccine, \"Covaxin\", and it needs around 1,500 volunteers for the purpose

Maulana Azad Medical College (MAMC) has selected three doctors as 'vaccinating officers' who will train more vaccinating officers, who then would pass it on to district-level healthcare workers

As of now, the Hyderabad-based manufacturer is in Phase III of its candidate's clinical trials, having over 25,800 volunteers across 18 sites in the country

Rapid antigen detection test directly detects presence or absence of coronavirus antigen in patient's body, generating results in 15-20 minutes; ICMR-approved CIPtest is found to have specificity and sensitivity of 98.09 per cent and up to 75 per cent

India Stock Market Highlights Today: Global equities were buoyed today as COVID-19 vaccine developments and prospects of more stimulus boosted investor sentiment

The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) sought additional safety and efficacy data for COVID-19 vaccine candidates of Bharat Biotech after deliberating upon its applications seeking emergency use authorisation for the shots

VK Paul says globally, 33 vaccines are in clinical trial phase, of which 10 vaccines are in advanced trial phase. Key consideration while prioritising population for vaccine inoculation is accessing people with risk to mortality and protection of healthcare system and response system

Out of 22,000 volunteers, the company has already recruited around 8,000 volunteers, says Krishna Ella, Chairman and Managing Director of Bharat Biotech

Several experts have raised questions about Bharat Biotech applying for emergency usage as Covaxin is still going through an efficacy trial. However, the ICMR has backed Bharat Biotech's move

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation

Union Health Ministry informed that the current cold chain system in India consists of 85,634 equipments for storage of vaccine at about 28,947 cold chain points across the country

All India Bank Officers' Confederation (AIBOC), All India Bank Officers' Association (AIBOA), Indian National Bank Officers' Congress (INBOC) and National Organisation of Bank Officers (NOBO) have jointly written the letter to the finance minister